Julia Irena Paczkowska, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hodgkin Disease | 5 | 2024 | 1383 | 1.860 |
Why?
|
| MicroRNAs | 6 | 2023 | 3784 | 0.820 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 734 | 0.660 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 1027 | 0.620 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 1059 | 0.540 |
Why?
|
| Reed-Sternberg Cells | 2 | 2024 | 78 | 0.410 |
Why?
|
| Immunity, Innate | 1 | 2024 | 3078 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 4405 | 0.390 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 751 | 0.390 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3948 | 0.370 |
Why?
|
| Gene Deletion | 1 | 2019 | 2666 | 0.370 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 5336 | 0.330 |
Why?
|
| DNA Methylation | 6 | 2021 | 4425 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-maf | 2 | 2021 | 69 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 4038 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 5781 | 0.280 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3818 | 0.270 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 2918 | 0.270 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3593 | 0.210 |
Why?
|
| Laryngeal Neoplasms | 2 | 2017 | 512 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 4 | 2021 | 5787 | 0.200 |
Why?
|
| Sezary Syndrome | 1 | 2020 | 70 | 0.170 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 582 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2019 | 12123 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 4779 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 17062 | 0.150 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2023 | 1376 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2023 | 8603 | 0.150 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2017 | 18 | 0.140 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2017 | 58 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 943 | 0.130 |
Why?
|
| CpG Islands | 1 | 2020 | 1207 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2015 | 89 | 0.130 |
Why?
|
| Genetics, Population | 1 | 2020 | 943 | 0.120 |
Why?
|
| Monocytes | 1 | 2024 | 2594 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1434 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2020 | 2926 | 0.110 |
Why?
|
| Heterozygote | 1 | 2019 | 2795 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4255 | 0.090 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2017 | 949 | 0.090 |
Why?
|
| Macrophages | 1 | 2024 | 5772 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1959 | 0.080 |
Why?
|
| Placenta | 1 | 2017 | 1728 | 0.070 |
Why?
|
| Biopsy | 1 | 2019 | 6754 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7599 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2021 | 515 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11007 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10428 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 765734 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12769 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2023 | 87 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7849 | 0.050 |
Why?
|
| Transcription Factor TFIIH | 1 | 2023 | 33 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9522 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 11888 | 0.050 |
Why?
|
| Proteins | 1 | 2017 | 5996 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 545 | 0.040 |
Why?
|
| Germinal Center | 1 | 2023 | 379 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2023 | 583 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2023 | 569 | 0.040 |
Why?
|
| Mycosis Fungoides | 1 | 2020 | 154 | 0.040 |
Why?
|
| Mutation | 2 | 2021 | 30184 | 0.040 |
Why?
|
| Cell Line | 2 | 2023 | 15542 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2021 | 1213 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 8626 | 0.030 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 385 | 0.030 |
Why?
|
| Female | 6 | 2024 | 395961 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 1075 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 752 | 0.030 |
Why?
|
| China | 1 | 2020 | 2386 | 0.030 |
Why?
|
| Male | 5 | 2024 | 363585 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3423 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1856 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 647 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2021 | 2862 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 532 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3404 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1926 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3794 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8279 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 3558 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11201 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 171050 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 222903 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23589 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 222974 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81792 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59459 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 30248 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 168731 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59852 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 88781 | 0.000 |
Why?
|